Recently, strategies targeting the NPY signaling pathway have been explored for obesity and diabetes interventions in animal studies, and some exciting metabolic benefits have been reported [48–52]. This evidence concerns the gene NPY and obesity due to melanocortin 4 receptor deficiency.